PHI with Bursitis
How does this condition affect your private health insurance?
Schleimbeutelentzündung, or bursitis, is the inflammation of a bursa, a small fluid-filled sac that reduces friction between bones, tendons, and muscles near joints. It commonly affects the shoulders, elbows, hips, and knees. Symptoms include localized pain, tenderness, swelling, and restricted movement in the affected joint. Causes often include repetitive motion, overuse, direct trauma, prolonged pressure, or underlying conditions like gout or rheumatoid arthritis. While typically not severe, untreated or recurrent bursitis can lead to chronic discomfort and functional limitations. Diagnosis is primarily clinical, sometimes aided by imaging.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically 2-6 weeks with appropriate treatment.
Duration of Illness (Lifetime)
Can be a one-time event; however, it may recur or become chronic if predisposing factors persist or are not addressed.
Cost of Treatment (Initial)
Moderate (e.g., doctor visits, anti-inflammatory medications, physical therapy, possibly a corticosteroid injection).
Cost of Treatment (Lifetime)
Variable; low for a single, resolved episode, but can be higher for recurrent cases requiring ongoing therapy, multiple injections, or, rarely, surgical intervention.
Mortality Rate
Extremely low; almost negligible, unless complicated by severe, uncontrolled infection leading to sepsis (very rare).
Risk of Secondary Damages
Low to moderate. Potential for chronic pain, limited range of motion, muscle atrophy, or calcification if left untreated or if recurrent. Septic bursitis (infection) can occur.
Probability of Full Recovery
High for acute cases with conservative treatment. Most individuals recover fully without lasting consequences.
Underlying Disease Risk
Low to moderate. May be associated with conditions like gout, rheumatoid arthritis, diabetes, thyroid disease, or occupational/recreational activities involving repetitive strain.